Respiratory Aspiration  >>  Semprana (dihydroergotamine oral inhalation)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Semprana (dihydroergotamine oral inhalation) / AbbVie
NCT01191723: QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo

Checkmark P1 data
Aug 2012 - Aug 2012: P1 data
Completed
1
54
US
MAP0004, Inhaler Placebo, Moxifloxacin, Avelox®, Placebo Capsule
Allergan, MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan
Healthy
09/10
09/10

Download Options